Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb;9(1):106-108.
doi: 10.21037/hbsn.2019.08.11.

Independent regulation of tumorigenesis and fibrosis in non-alcoholic fatty liver disease

Affiliations
Editorial

Independent regulation of tumorigenesis and fibrosis in non-alcoholic fatty liver disease

Rhys Gillman et al. Hepatobiliary Surg Nutr. 2020 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Graphical model of the findings by Grohmann et al. (3) STAT-1 and STAT-3 can independently promote either NASH and fibrosis, or HCC respectively. NASH, non-alcoholic steatohepatitis; HCC, hepatocellular carcinoma.

Comment on

  • Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.
    Grohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, Rasmiena AA, Kaur S, Gulati T, Goh PK, Treloar AE, Archer S, Brown WA, Muller M, Watt MJ, Ohara O, McLean CA, Tiganis T. Grohmann M, et al. Cell. 2018 Nov 15;175(5):1289-1306.e20. doi: 10.1016/j.cell.2018.09.053. Epub 2018 Oct 25. Cell. 2018. PMID: 30454647 Free PMC article.

References

    1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128. 10.1016/S0140-6736(12)61728-0 - DOI - PMC - PubMed
    1. Kodama K, Kawaguchi T, Hyogo H, et al. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. J Gastroenterol Hepatol 2019. [Epub ahead of print]. 10.1111/jgh.14608 - DOI - PubMed
    1. Grohmann M, Wiede F, Dodd GT, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell 2018;175:1289-306.e20. 10.1016/j.cell.2018.09.053 - DOI - PMC - PubMed
    1. Karin M. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precis Clin Med 2018;1:21-8. 10.1093/pcmedi/pby005 - DOI - PMC - PubMed
    1. Regis G, Pensa S, Boselli D, et al. Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol 2008;19:351-9. 10.1016/j.semcdb.2008.06.004 - DOI - PubMed